Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan 1;1(1):4-8.
doi: 10.1021/ml900003t.

Mechanistic studies of Sansalvamide A-amide: an allosteric modulator of Hsp90

Robert C Vasko  1 , Rodrigo A Rodriguez, Christian N Cunningham, Veronica C Ardi, David A Agard, Shelli R McAlpine
Affiliations

Mechanistic studies of Sansalvamide A-amide: an allosteric modulator of Hsp90

Robert C Vasko et al. ACS Med Chem Lett. .

Abstract

Herein we show that San A-amide, a structurally unique molecule, influences a subset of cancer-related pathways involving Hsp90. We show that San A-amide specifically binds to the N-middle domain of Hsp90 allosterically disrupts the binding of proteins thought to interact with the Hsp90 C-terminal domain, while having no effect on an N-terminal domain client protein. This unique mechanism suggests that San A-amide is a potential tool for studying C-terminal binding proteins of Hsp90 as well as a promising lead in the development of new cancer therapeutics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
(a) Natural product San A, the derivative San A-amide compound (1), and biotinylated San A-amide (San A-amide-Biotin). (b) Schematic diagram of the pull-down assay.
Figure 2
Figure 2
Bands isolated in the pull-down assay using HCT-116 colon cancer cell lyate. Lanes: 1 and 5, MW marker (kDa); 2, San A-amide-Biotin; 3, negative control (PEGlayted biotin linker); 4, DMSO control; and 6−8, protein input for lanes 2−4, respectively. Major proteins are indicated by asterisks with the following order from top to bottom: Hsp90, keratin, α- and β-tubulin, and actin.
Figure 3
Figure 3
In vitro pull-down binding assay: (a) San A-amide inhibits binding of both IP6K2 (EC50 = ∼1.4 μM) and the FKBP (EC50 = 1.0 μM) to Hsp90. Her2 binding to Hsp90 is not affected. (b) 17AAG inhibits Her2 binding to Hsp90 (EC50 = ∼0.66 μM), while FKBP and IP6K2 binding to Hsp90 are not affected (IP6K2 is not inhibited at 10 μM). %Hsp90 bound to client protein was quantified by densitometric scanning of Hsp90 protein on Western blot with normalization to client protein loading using Image J.
Figure 4
Figure 4
Cytotoxicity of San A-amide in IP6K2 overexpressed cell line (K2-O/E, gray bar) as compared to wild-type control (Con, white bar). *p < 0.05; ***p < 0.001.
Figure 5
Figure 5
San A-amide pull down of Hsc82 (yeast variant of Hsp90) full length and domains. Lanes: 1, MW marker (kDa); 2, N-terminal domain; 3, middle domain; 4, C-terminal domain; 5, N-terminal and middle domain combined; and 6, full length.
See this image and copyright information in PMC

References

    1. Cueto M.; Jensen P. R.; Fenical W. N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus Fusarium. Phytochemistry 2000, 55, 223–226. - PubMed
    1. Belofsky G. N.; Jensen P. R.; Fenical W. Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium. Tetrahedron Lett. 1999, 40, 2913–2916.
    1. Hwang Y.; Rowley D.; Rhodes D.; Gertsch J.; Fenical W.; Bushman F. Mechanism of Inhibition of a Poxvirus Topoisomerase by the Marine Natural Product Sansalvamide A. Mol. Pharmacol. 1999, 55, 1049–1053. - PubMed
    1. Otrubova K.; Lushington G. H.; Vander Velde D.; McGuire K. L.; McAlpine S. R. A Comprehensive Study of Sansalvamide A Derivatives and Their Structure-Activity Relationships against Drug-Resistant Colon Cancer Cell Lines. J. Med. Chem. 2008, 51, 530–544. - PubMed
    1. Pan P. S.; Vasko R. C.; Lapera S. A.; Johnson V. A.; Sellers R. P.; Lin C.-C.; Pan C.-M.; Davis M. R.; Ardi V. C.; McAlpine S. R. A comprehensive study of Sansalvamide A derivatives: Their structure-activity relationships and their binding mode to Hsp90. Bioorg. Med. Chem. 2009, 17, 5806–5825. - PMC - PubMed